From January 20-21, the United States hosted the inaugural meeting of the U.S.-India Drug Policy Executive Working Group in Washington, D.C. The Oļ¬ce of National Drug Control Policyās (ONDCP) Director, Sara Carter, opened the meeting by emphasizing President Trump and Prime Minister Modiās mutual commitment to strengthening security cooperation and eradicating narco-terrorism. Ambassador Vinay Kwatra, Ambassador of India to the United States of America, stated that India accorded the highest priority to addressing the threat posed by narcotics trafficking and the diversion of precursor chemicals, while also balancing effective enforcement with facilitation of legitimate trade. The Executive Working Group, led by ONDCPās Acting Deputy Director, Debbie Seguin, and the Narcotics Control Bureauās Deputy Director General, Monika Ashish Batra, worked with the U.S. and Indian delegations, respectively, to deliver tangible, measurable outcomes in advancing the critical counter narcotics partnership.
āThe drug crisis is now a core national security priority,ā said Director Carter. This Executive Working Group leverages the bilateral partnership to protect families while also supporting legitimate industries.
Both countries committed to strengthening bilateral cooperation to dismantle the illegal production and traļ¬cking of illicit drugs and their precursor chemicals that threaten our communities. They emphasized the importance of a whole-of-government approach that streamlines interagency and intergovernmental eļ¬orts and secures the pharmaceutical supply chain, consistent with respective national rules and regulations, while also building upon the success of recent joint operations to disrupt illicit narcotic traļ¬cking networks.
This meeting highlights the United Statesā and Indiaās enduring and shared commitment to addressing the global drug challenge and fostering a safer and healthier future for both nations.